Opinion: The U.S. pharmaceutical supply chain problem is not about China
Pooja Yerramilli·
·1 min read
·
0 reactions
·
0 comments
·
7 views
The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction, writes Pooja Yerramilli.
About this source
STAT News files mainly under health. We currently carry 204 of its stories.
Original article
STAT · Pooja Yerramilli
Anonymous · no account needed
Discussion
0 commentsMore from STAT
Opinion: I may be one of the last middle-class medical students who could afford to become a doctor
STAT·6
Senate advances MAHA-friendly bill for food warning labels and junk food ad bans
STAT·6
STAT+: White House offers its science blueprint: More AI, less life sciences
STAT·4
STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
STAT·4
STAT+: What’s in the last-minute flurry of health care bills?
STAT·11
Trump administration says it’s deferring $1B in Medicaid payments to California and Minnesota
STAT·11